×
Request Free Sample ×
Topical Corticosteroids Market – Research Report Forecast till 2035 Infographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Topical Corticosteroids Market

ID: MRFR/Pharma/2945-HCR
128 Pages
Rahul Gotadki
October 2025

Topical Corticosteroids Market Research Report By Application (Dermatology, Ophthalmology, Rheumatology, Allergy), By Formulation (Creams, Ointments, Lotions, Gels), By Potency (High Potency, Medium Potency, Low Potency), By Patient Type (Pediatric, Adult, Geriatric) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Topical Corticosteroids Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Topical Corticosteroids Market Summary

As per Market Research Future analysis, the Topical Corticosteroids Market Size was estimated at 4347.23 USD Million in 2024. The Topical Corticosteroids industry is projected to grow from 4668.26 USD Million in 2025 to 8496.08 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 6.24% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Topical Corticosteroids Market is experiencing robust growth driven by increasing demand and technological advancements.

  • The rising incidence of skin disorders is propelling the demand for topical corticosteroids, particularly in North America.
  • Advancements in formulation technology are enhancing the efficacy and safety profiles of topical corticosteroids, appealing to both dermatology and pediatric segments.
  • Regulatory developments and safety concerns are shaping market dynamics, especially in the Asia-Pacific region, which is the fastest-growing market.
  • Key drivers such as the increasing prevalence of allergic reactions and the aging population are significantly influencing market growth.

Market Size & Forecast

2024 Market Size 4347.23 (USD Million)
2035 Market Size 8496.08 (USD Million)
CAGR (2025 - 2035) 6.24%

Major Players

Pfizer (US), Bristol-Myers Squibb (US), GlaxoSmithKline (GB), Mylan (US), Novartis (CH), Sanofi (FR), AbbVie (US), Hikma Pharmaceuticals (GB), Teva Pharmaceutical Industries (IL)

Topical Corticosteroids Market Trends

The Topical Corticosteroids Market is currently experiencing a notable evolution, driven by a combination of factors including increasing prevalence of skin disorders and rising awareness regarding effective treatment options. The market appears to be expanding as healthcare professionals and patients alike recognize the benefits of topical corticosteroids in managing conditions such as eczema, psoriasis, and dermatitis. Furthermore, the growing emphasis on dermatological health and the development of innovative formulations are likely to enhance the market's appeal. As a result, the landscape of topical corticosteroids is becoming increasingly competitive, with various players striving to introduce advanced products that cater to diverse patient needs. In addition, the regulatory environment surrounding topical corticosteroids is evolving, which may influence market dynamics. Regulatory bodies are focusing on ensuring the safety and efficacy of these medications, potentially leading to more stringent approval processes. This could impact the speed at which new products enter the market. However, the ongoing research and development efforts in this field suggest that the Topical Corticosteroids Market will continue to thrive, as stakeholders seek to address unmet medical needs and improve patient outcomes. Overall, the market appears poised for growth, driven by innovation, awareness, and a commitment to enhancing dermatological care.

Rising Incidence of Skin Disorders

The increasing prevalence of skin conditions such as eczema and psoriasis is driving demand for topical corticosteroids. As more individuals seek effective treatments, the market is likely to expand, with healthcare providers recommending these therapies as first-line options.

Advancements in Formulation Technology

Innovations in formulation technology are enhancing the efficacy and safety profiles of topical corticosteroids. New delivery systems and combination therapies are emerging, which may improve patient compliance and treatment outcomes, thereby influencing market growth.

Regulatory Developments and Safety Concerns

The evolving regulatory landscape surrounding topical corticosteroids is shaping market dynamics. Stricter safety evaluations and guidelines may impact product availability, but they also aim to ensure patient safety, potentially leading to more trusted therapies.

Topical Corticosteroids Market Drivers

Rising Prevalence of Skin Disorders

The increasing incidence of skin disorders globally is a primary driver for the Global Topical Corticosteroids Market Industry. Conditions such as eczema, psoriasis, and dermatitis are becoming more prevalent, affecting millions of individuals. For instance, the World Health Organization indicates that eczema affects approximately 15-20% of children and 1-3% of adults worldwide. This growing patient population necessitates effective treatment options, thereby propelling the demand for topical corticosteroids. As the market is projected to reach 8.25 USD Billion in 2024, the need for effective management of these skin conditions is likely to sustain growth in the industry.

Market Segment Insights

By Application: Dermatology (Largest) vs. Pediatric (Fastest-Growing)

In the Topical Corticosteroids Market, dermatology stands out as the largest application segment, driven by the prevalence of skin conditions such as eczema, psoriasis, and dermatitis. This segment holds a significant portion of the market, reflecting its critical role in managing various dermatological disorders. On the other hand, the pediatric segment is emerging rapidly, gaining traction due to an increase in awareness of skin ailments in young populations and the importance of using safe, effective treatments designed specifically for children.

Dermatology (Dominant) vs. Pediatric (Emerging)

Dermatology is the dominant segment of the Topical Corticosteroids Market, characterized by a wide range of products targeting issues such as inflammation and allergic reactions of the skin. This segment benefits from extensive research and advancement in formulations catering to diverse dermatological needs. In contrast, the pediatric segment is identified as an emerging market, fueled by growing recognition of skin health in children. Pediatric formulations tend to be designed for enhanced safety and comfort, catering specifically to younger patients who require gentler solutions. The growth in pediatric usage is reflective of increased health campaigns emphasizing the treatment of skin conditions in children.

By Formulation Type: Cream (Largest) vs. Ointment (Fastest-Growing)

In the Topical Corticosteroids Market, the formulation types exhibit varying degrees of market share. Creams hold the largest share due to their versatility and consumer preference for easy application. They are favored in various dermatological conditions, making them a top choice for both patients and healthcare providers. Ointments, while not as widely used as creams, are gaining traction and are recognized for their effectiveness in providing a barrier effect, thus catering to specific skin conditions that require prolonged moisture retention.

Cream (Dominant) vs. Gel (Emerging)

Creams are the dominant formulation in the Topical Corticosteroids Market, offering a balance between efficacy and ease of use. Their ability to absorb quickly and provide a moisturizing effect makes them popular among users. In contrast, gels are emerging as a preferred choice, particularly among younger demographics due to their lightweight feel and fast absorption. Gels are becoming increasingly popular for treating inflammatory skin conditions, as they provide a non-greasy option that many consumers prefer. As awareness of their benefits rises, gels are set to carve out a larger market share in the coming years.

By Potency: High Potency (Largest) vs. Low Potency (Fastest-Growing)

In the Topical Corticosteroids Market, the segment distribution reveals that high potency corticosteroids command a significant market share due to their effectiveness in treating severe inflammatory skin conditions. Conversely, low potency corticosteroids, once considered less impactful, have seen a sizable boost in usage driven by changes in prescribing practices and patient preferences for gentler treatments. Furthermore, clinicians are increasingly opting for low potency options in initial treatment protocols, which enhances their market presence. Growth trends in this segment are fueled by rising awareness among patients and healthcare providers regarding the safety and efficacy of various potency levels. The increasing incidence of skin diseases, such as eczema and psoriasis, and the demand for personalized medicine further contribute to the market's dynamics. Low potency corticosteroids are gaining traction among patients for their safety profile, while high potency options remain preferred for rapid resolution of acute flare-ups, showcasing a balanced growth framework in this segment.

High Potency (Dominant) vs. Low Potency (Emerging)

High potency topical corticosteroids are recognized for their enhanced efficacy in treating severe dermatological conditions. This segment dominates the market owing to its strong therapeutic outcomes, particularly in challenging cases of dermatological inflammation. These products are often prescribed for short-term management of acute exacerbations, allowing rapid healing. On the other hand, low potency corticosteroids are emerging as the preferred choice for long-term management and maintenance therapy. Their safety profile and minimal side effects make them attractive to patients seeking gentler options. As healthcare providers emphasize patient adherence and safety, the low potency segment is witnessing significant growth, complimenting the established high potency category in the treatment landscape.

By Route of Administration: Topical (Largest) vs. Transdermal (Fastest-Growing)

In the Topical Corticosteroids Market, the distribution among the routes of administration reveals Topical as the dominant segment, accounting for the majority share due to its direct application onto affected areas and immediate therapeutic effects. Transdermal administration is emerging quickly, driven by advancements in microneedle and permeation enhancer technologies, allowing for deeper penetration and sustained drug release, which appeals to both healthcare providers and patients seeking more effective treatment modalities.

Administration Methods: Topical (Dominant) vs. Transdermal (Emerging)

Topical corticosteroids are primarily applied directly onto the skin, offering localized targeted treatment which leads to quicker onset of action, making it the preferred method in dermatological conditions like eczema and psoriasis. The segment has a robust and established presence in the market, characterized by a wide range of formulations such as creams, ointments, and lotions. In contrast, transdermal corticosteroids utilize innovative delivery systems to allow the drug to be absorbed through the skin, providing longer-lasting effects and minimizing systemic side effects. This emerging segment is gaining traction among patients and healthcare providers due to its convenience and effectiveness in treating dermatological conditions.

By Patient Demographics: Adults (Largest) vs. Children (Fastest-Growing)

In the Topical Corticosteroids Market, adults constitute the largest demographic segment, attributable to the high prevalence of skin disorders and inflammatory conditions in this age group. With increasing awareness and accessibility of topical treatments, adults represent a significant portion of the consumer base, driving steady demand for various corticosteroid products. Meanwhile, children are emerging as the fastest-growing segment, driven by rising incidences of pediatric dermatological conditions and an increasing parental focus on effective treatments for skin issues in children. The growth trends in this demographic segment are influenced by various factors, including the rising prevalence of skin conditions like eczema and psoriasis across all age groups, but particularly pronounced in children. Parents are increasingly advised by healthcare professionals to use topical corticosteroids for managing conditions in children, promoting stronger demand in this emerging segment. Additionally, the unique formulation and packaging of products for pediatric use enhance market growth, catering specifically to children’s sensitive skin needs.

Adults (Dominant) vs. Pregnant Women (Emerging)

Adults form the dominant segment in the Topical Corticosteroids Market due to their high incidence of skin diseases and the need for effective management solutions. This group's characteristics include a broader range of skin issues that necessitate corticosteroid treatments, from allergic reactions to chronic conditions. On the other hand, pregnant women represent an emerging segment, characterized by the specialized needs of expectant mothers for safe and effective topical treatments. The market for this demographic is evolving as healthcare providers focus on approved formulations that minimize risks to both mothers and their unborn children. As awareness of dermatological needs during pregnancy rises, more product lines tailored to this segment are expected to enter the market, fostering growth opportunities for manufacturers.

Get more detailed insights about Topical Corticosteroids Market
Request Free Sample

Regional Insights

North America : Market Leader in Growth

North America continues to lead the Topical Corticosteroids market, holding a significant share of 2173.62 million in 2024. The growth is driven by increasing incidences of skin disorders, heightened awareness of treatment options, and robust healthcare infrastructure. Regulatory support and innovation in drug formulations further catalyze market expansion, making it a focal point for pharmaceutical investments. The United States is the primary contributor, with major players like Pfizer, AbbVie, and Mylan dominating the landscape. The competitive environment is characterized by continuous product launches and strategic collaborations. The presence of established companies ensures a steady supply of advanced corticosteroid treatments, catering to diverse patient needs and preferences.

Europe : Emerging Market Dynamics

Europe's Topical Corticosteroids market is valued at 1303.0 million, reflecting a growing demand driven by rising skin conditions and an aging population. Regulatory frameworks in the EU promote innovation and safety, encouraging companies to invest in research and development. The market is also influenced by increasing healthcare expenditure and awareness of dermatological treatments, contributing to its expansion. Leading countries include Germany, France, and the UK, where key players like GlaxoSmithKline and Sanofi are prominent. The competitive landscape is marked by a mix of established firms and emerging biotech companies, fostering innovation. The region's regulatory bodies ensure compliance and safety, enhancing consumer trust in topical corticosteroid products.

Asia-Pacific : Rapidly Growing Market

The Asia-Pacific region, with a market size of 700.0 million, is witnessing rapid growth in the Topical Corticosteroids sector. Factors such as increasing urbanization, rising disposable incomes, and a growing prevalence of skin diseases are driving demand. Additionally, government initiatives aimed at improving healthcare access and affordability are further propelling market growth, making it a key area for investment. Countries like China, India, and Japan are leading the charge, with a mix of local and international players like Novartis and Teva Pharmaceutical Industries. The competitive landscape is evolving, with companies focusing on product differentiation and strategic partnerships to capture market share. The region's diverse population presents unique challenges and opportunities for tailored corticosteroid solutions.

Middle East and Africa : Untapped Market Opportunities

The Middle East and Africa region, valued at 170.61 million, presents untapped opportunities in the Topical Corticosteroids market. The growth is driven by increasing awareness of skin health, rising healthcare investments, and a growing population. Regulatory bodies are beginning to establish frameworks that support the introduction of new treatments, which is crucial for market expansion in this region. Countries like South Africa and the UAE are at the forefront, with a mix of local and international companies vying for market presence. The competitive landscape is characterized by a focus on affordability and accessibility of treatments. Key players are exploring partnerships and collaborations to enhance their market reach and cater to the diverse needs of the population.

Key Players and Competitive Insights

The Topical Corticosteroids Market is characterized by a dynamic competitive landscape, driven by increasing incidences of dermatological conditions and a growing demand for effective treatment options. Major players such as Pfizer (US), AbbVie (US), and GlaxoSmithKline (GB) are strategically positioned to leverage innovation and expand their product portfolios. Pfizer (US) focuses on enhancing its research capabilities to develop novel formulations, while AbbVie (US) emphasizes strategic partnerships to bolster its market presence. GlaxoSmithKline (GB) appears to be investing in digital transformation initiatives to streamline operations and improve customer engagement, collectively shaping a competitive environment that prioritizes innovation and responsiveness to market needs.

Key business tactics within the market include localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The competitive structure is moderately fragmented, with several key players exerting influence over market dynamics. This fragmentation allows for a diverse range of products and strategies, fostering competition that drives innovation and improves patient outcomes.

In November 2025, AbbVie (US) announced a collaboration with a leading biotechnology firm to develop a new topical corticosteroid aimed at treating chronic skin conditions. This strategic move is likely to enhance AbbVie's product offerings and strengthen its position in the market, as it seeks to address unmet medical needs through innovative solutions. The partnership underscores the importance of collaboration in advancing therapeutic options and reflects a broader trend towards integrated approaches in drug development.

In October 2025, Pfizer (US) launched a new digital platform designed to facilitate patient access to its topical corticosteroid products. This initiative not only aims to improve patient adherence but also positions Pfizer as a leader in leveraging technology to enhance healthcare delivery. The platform's introduction may significantly impact patient engagement and satisfaction, thereby influencing market share in a competitive landscape increasingly focused on digital solutions.

In September 2025, GlaxoSmithKline (GB) expanded its manufacturing capabilities in Europe to meet rising demand for its topical corticosteroid products. This expansion is indicative of GSK's commitment to ensuring supply chain reliability and responsiveness to market fluctuations. By enhancing its production capacity, GSK is likely to strengthen its competitive edge and maintain a robust presence in the market.

As of December 2025, current trends in the Topical Corticosteroids Market include a pronounced shift towards digitalization, sustainability, and the integration of artificial intelligence in product development and marketing strategies. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise. Looking ahead, competitive differentiation is expected to evolve, with a notable shift from price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This transition may redefine market dynamics, emphasizing the importance of delivering high-quality, effective treatments that meet the evolving needs of patients.

Key Companies in the Topical Corticosteroids Market market include

Industry Developments

  • Q2 2024: LEO Pharma receives FDA approval for Adbry® (tralokinumab-ldrm) for the treatment of moderate-to-severe atopic dermatitis in adults LEO Pharma announced that the U.S. FDA approved Adbry® (tralokinumab-ldrm), a biologic for moderate-to-severe atopic dermatitis, expanding its dermatology portfolio which includes topical corticosteroids.
  • Q1 2024: GSK announces launch of new topical corticosteroid cream Betnovate™ in select European markets GlaxoSmithKline launched Betnovate™, a new formulation of its established topical corticosteroid, in several European countries to address unmet needs in dermatological care.
  • Q2 2024: AstraZeneca and LEO Pharma enter strategic partnership to co-develop next-generation topical corticosteroids AstraZeneca and LEO Pharma announced a partnership to jointly develop and commercialize innovative topical corticosteroid therapies for inflammatory skin diseases.
  • Q2 2024: Pfizer opens new dermatology R&D facility in Cambridge, Massachusetts Pfizer inaugurated a new research and development facility focused on dermatology, including the development of advanced topical corticosteroid formulations.
  • Q1 2024: Sanofi appoints Dr. Maria Lopez as Global Head of Dermatology Franchise Sanofi announced the appointment of Dr. Maria Lopez to lead its global dermatology franchise, which includes its topical corticosteroid product lines.
  • Q2 2024: Bausch Health receives Health Canada approval for new topical corticosteroid lotion for eczema Bausch Health announced Health Canada approval for its new prescription topical corticosteroid lotion indicated for the treatment of eczema in adults and children.
  • Q1 2024: Cipla launches generic mometasone furoate cream in the US market Cipla announced the launch of its generic version of mometasone furoate topical corticosteroid cream in the United States, expanding its dermatology portfolio.
  • Q2 2024: Novartis invests $50 million in topical corticosteroid manufacturing expansion in Switzerland Novartis announced a $50 million investment to expand its manufacturing capacity for topical corticosteroids at its Swiss facility to meet growing global demand.
  • Q1 2024: Sun Pharma receives US FDA approval for Halobetasol Propionate Ointment Sun Pharma received US FDA approval for its Halobetasol Propionate Ointment, a high-potency topical corticosteroid for the treatment of plaque psoriasis.
  • Q2 2024: Dr. Reddy's launches Betamethasone Dipropionate Ointment in the US Dr. Reddy's Laboratories announced the launch of Betamethasone Dipropionate Ointment USP, a topical corticosteroid, in the US market.
  • Q1 2024: Galderma announces partnership with Almirall to co-market topical corticosteroid products in Europe Galderma and Almirall entered a co-marketing agreement to promote and distribute select topical corticosteroid products across European markets.
  • Q2 2024: Teva launches generic clobetasol propionate foam in the US Teva announced the US launch of its generic clobetasol propionate topical foam, expanding its dermatology generics portfolio.

Future Outlook

Topical Corticosteroids Market Future Outlook

The Topical Corticosteroids Market is projected to grow at a 6.24% CAGR from 2024 to 2035, driven by increasing prevalence of skin disorders and advancements in drug formulations.

New opportunities lie in:

  • Development of personalized topical corticosteroid therapies
  • Expansion into emerging markets with tailored marketing strategies
  • Investment in digital healthcare platforms for patient engagement

By 2035, the market is expected to achieve robust growth, solidifying its position as a key segment in dermatological treatments.

Market Segmentation

Topical Corticosteroids Market Potency Outlook

  • Low Potency
  • Medium Potency
  • High Potency
  • Super High Potency

Topical Corticosteroids Market Application Outlook

  • Dermatology
  • Pediatric
  • Geriatric
  • Ophthalmology

Topical Corticosteroids Market Formulation Type Outlook

  • Cream
  • Ointment
  • Lotion
  • Gel

Topical Corticosteroids Market Patient Demographics Outlook

  • Adults
  • Children
  • Elderly
  • Pregnant Women

Topical Corticosteroids Market Route of Administration Outlook

  • Topical
  • Transdermal
  • Intralesional

Report Scope

MARKET SIZE 2024 4347.23(USD Million)
MARKET SIZE 2025 4668.26(USD Million)
MARKET SIZE 2035 8496.08(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 6.24% (2024 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Pfizer (US), Bristol-Myers Squibb (US), GlaxoSmithKline (GB), Mylan (US), Novartis (CH), Sanofi (FR), AbbVie (US), Hikma Pharmaceuticals (GB), Teva Pharmaceutical Industries (IL)
Segments Covered Application, Formulation Type, Potency, Route of Administration, Patient Demographics
Key Market Opportunities Emerging formulations and personalized treatments drive growth in the Topical Corticosteroids Market.
Key Market Dynamics Rising demand for topical corticosteroids drives innovation and regulatory scrutiny in formulation and distribution practices.
Countries Covered North America, Europe, APAC, South America, MEA

Market Highlights

Author
Rahul Gotadki
Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

Leave a Comment

FAQs

What is the projected market size of the Global Topical Corticosteroids Market in 2032?

The Global Topical Corticosteroids Market is projected to be valued at 11.2 USD Billion in 2032.

What is the expected CAGR for the Global Topical Corticosteroids Market from 2024 to 2032?

The expected CAGR for the Global Topical Corticosteroids Market from 2024 to 2032 is 3.8%.

Which application segment is expected to have the largest market share in 2032?

The Dermatology application segment is expected to have the largest market share valued at 5.6 USD Billion in 2032.

How is the North American market for Topical Corticosteroids expected to evolve by 2032?

The North American market for Topical Corticosteroids is expected to grow to 4.55 USD Billion by 2032.

What is the market size for the Ophthalmology application of Topical Corticosteroids in 2023?

The market size for the Ophthalmology application of Topical Corticosteroids is valued at 1.5 USD Billion in 2023.

Which key players are leading the Global Topical Corticosteroids Market?

Key players in the Global Topical Corticosteroids Market include Bristol-Myers Squibb, Sanofi, and AbbVie.

What is the expected market value for the Rheumatology application by 2032?

The expected market value for the Rheumatology application by 2032 is 1.6 USD Billion.

What is the projected market value for the Allergy application in 2032?

The projected market value for the Allergy application in 2032 is 2.0 USD Billion.

How is the APAC region anticipated to contribute to the Topical Corticosteroids Market by 2032?

The APAC region is anticipated to contribute 2.1 USD Billion to the Topical Corticosteroids Market by 2032.

What is the market value for the South America region in 2023?

The market value for the South America region in 2023 is valued at 0.65 USD Billion.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

No regional reports available for this market.

Customer Stories
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓